Use of a Synthetic Cannabinoid in a Correctional Population for Posttraumatic Stress Disorder–Related Insomnia and Nightmares, Chronic Pain, Harm Reduction, and Other Indications-Reference-Cited by-同舟云学术

Use of a Synthetic Cannabinoid in a Correctional Population for Posttraumatic Stress Disorder–Related Insomnia and Nightmares, Chronic Pain, Harm Reduction, and Other Indications

Published:2014-10 Issue:5 Volume:34 Page:559-564
ISSN:0271-0749
Container-title:Journal of Clinical Psychopharmacology
language:en
Short-container-title:

Author:

Cameron Colin,Watson Diane,Robinson Jeffrey

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Psychiatry and Mental health

Reference16 articles.

1. Cannabinoids for treatment of chronic non-cancer pain: a systematic review of randomized trials.;Lynch;Br J Clin Pharmacol,2011

2. Cannabinoid analgesia as a potential new therapeutic option in the treatment of chronic pain.;Burns;Ann Pharmacother,2006

3. The use of a synthetic cannabinoid in the management of treatment-resistant nightmares in posttraumatic stress disorder (PTSD).;Fraser;CNS Neurosci Ther,2009

4. Substitution profile of the cannabinoid agonist nabilone in human subjects discriminating delta-9-tertrahydrocannabinol.;Lile;Clin Neuropharmacol,2012

5. The abuse potential of the synthetic cannabinoid nabilone.;Ware;Addiction,2010

Cited by 141 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anandamide and disease. Role in stress, fear, and PTSD;Anandamide in Health and Disease;2025

2. Assessing rates and predictors of cannabis-associated psychotic symptoms across observational, experimental and medical research;Nature Mental Health;2024-06-03

3. Retrospective examination of cannabis vs. other substance misuse: Associations with 30-day readmission and global assessment of functioning in hospitalized patients with serious mental illness;Psychiatry Research Communications;2024-06

4. Cannabis donation as a harm reduction strategy: a case study;Harm Reduction Journal;2024-03-06

5. Cannabinoids in the Treatment of Selected Mental Illnesses: Practical Approach and Overview of the Literature;Pharmacopsychiatry;2024-03-01